New legislative proposals from the European Commission aim to reinforce cooperation among EU member states on health technology assessments (HTAs), including mandatory cooperation in joint clinical assessments, scientific dialogues, horizon scanning and voluntary cooperation in other areas. The proposals, which apply to innovative products, are a “positive step,” according to EFPIA, the European Federation of Pharmaceutical Industries and Associations.
Currently different member states have different procedures for HTA, which means a lack of predictability and higher costs for companies,...








